Bioactivity | KC 12291 hydrochloride is an orally active blocker of voltage-gated sodium channel (VGSC). KC 12291 hydrochloride reduces the amplitude of sustained Na+ current to exert antiischemic activity. KC 12291 hydrochloride has significant cardioprotective effect in vitro and in vivo[1]. |
Invitro | KC 12291 hydrochloride (1 μM) 降低了大约 60 % 大鼠心室心肌细胞的 Na+ 电流峰[1] 。 0 --> KC 12291 hydrochloride 相关抗体: |
In Vivo | KC 12291 hydrochloride (0.63 mg/kg,口服;1 次) 对麻醉兔模型有明显的抗缺血活性[1]。KC 12291 hydrochloride (60 mg/kg,口服) 在雌性和雄性小鼠中的血浆 Cmax 值分别为 1.3 和 1.4 μg/mL,血浆的 Tmax 值将近 2 小时[1]。 Animal Model: |
Name | KC 12291 hydrochloride |
CAS | 181936-98-1 |
Formula | C22H28ClN3O3S |
Molar Mass | 449.99 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. John GW, et al. KC 12291: an atypical sodium channel blocker with myocardial antiischemic properties. Cardiovasc Drug Rev. 2004 Spring;22(1):17-26. |